Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by M. Bednorz
EP16.89: Prediction of preeclampsia by maternal characteristics, sFlt-1, PLGF and their ratio for in women with new-onset pregnancy hypertension
No abstract is available for this article. Supporting Information Filename Description uog70305_1137-sup-0001-Supinfo.jpgimage/jpg, 6.8 MB Supporting Information
EP16.167: Antihypertensive treatment and longitudinal changes in PLGF and sFlt-1 in women with new-onset hypertension of pregnancy
No abstract is available for this article. Supporting Information Filename Description uog70305_1191-sup-0001-Supinfo.jpgimage/jpg, 4 MB Supporting Information Related Information Check for updates Issue Online: 31 August 2026 Version of Record online: 31 August 2026 Manuscript accepted: 06 July 2026 Scite uses AI to classify citations by whether they support, contradict, or merely mention the referenced claims.
Prediction using serum glycosylated fibronectin and angiogenic factors of superimposed pre‐eclampsia in women with chronic hypertension
REFERENCES 1, , , , . Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol 2017; 50: 228–235. 2, , , , , . Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 2014; 348: g2301. 3, , , , , , . Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks' gestation. Am J Obstet Gynecol 2016; 214: 103. e1–12. 4, , , , , , , , , , , , , , , , , , , .
Prediction using serum glycosylated fibronectin of imminent pre‐eclampsia in women with new‐onset hypertension
REFERENCES 1, , . Preeclampsia. N Engl J Med 2022; 386: 1817–1832. 2, , , , , , , , , , , , . Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649–658. 3, , , , , , , , , , , , . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–683. 4, , , , , , , , , , , .
Screening for pre‐eclampsia by maternal serum glycosylated fibronectin at 11−13 weeks' gestation
Supporting Information Filename Description uog26303-sup-0001-Tables.docxWord 2007 document , 13.9 KB Table S1 Model to define multiples of the median value of glycosylated fibronectin in pregnancies that deliver with pre-eclampsia Table S2 Correlation between log10-transformed multiples of the median values of glycosylated fibronectin and those of other biomarkers of pre-eclampsia REFERENCES 1, , , , , , , , , , , , , , , , , , , .
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with M.
Contact M., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack